Literature DB >> 16940214

Hypertension accelerated experimental abdominal aortic aneurysm through upregulation of nuclear factor kappaB and Ets.

Suguru Shiraya1, Ken Miwa, Motokuni Aoki, Takashi Miyake, Masako Oishi, Kazusaburo Kataoka, Shigetsugu Ohgi, Toshio Ogihara, Yasufumi Kaneda, Ryuichi Morishita.   

Abstract

In this study, we focused on the effect of hypertension on the transcription factors nuclear factor kappaB (NFkappaB) and ets in the mechanisms of abdominal aortic aneurysm (AAA), and we investigated how hypertension affects the progression of AAA. AAA was produced by elastase perfusion in hypertensive rats and normotensive rats. The size of AAA rapidly increased in hypertensive rats as compared with normotensive rats. Western blot analysis demonstrated that the expression of matrix metalloproteinase (MMP)-2, -3 , -9, and -12, as well as intercellular adhesion molecule, was increased in hypertensive AAA rats, accompanied by upregulation of NFkappaB and ets. Moreover, in situ zymography showed that the activity of MMPs was increased in the aorta of a hypertensive AAA model as compared with that in a normotensive AAA model. Interestingly, transfection of chimeric decoy oligodeoxynucleotide (ODN) resulted in significant inhibition of aortic dilatation both in normotensive and hypertensive rats at 4 weeks after transfection. Destruction of elastic fibers was also significantly inhibited by transfection of chimeric decoy ODN in both hypertensive rats and normotensive rats. The expression of MMP-2, -3, -9, and -12, as well as intercellular adhesion molecule, was significantly attenuated by the chimeric decoy ODN, accompanied by inhibition of the migration of macrophages. Also, the effect of chimeric decoy ODN was confirmed in an organ culture. The present study demonstrated that hypertension accelerated the progression of experimental AAA through upregulation of NFkappaB and ets. Inhibition of NFkappaB and ets could be a novel therapeutic strategy to treat AAA in hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16940214     DOI: 10.1161/01.HYP.0000240266.26185.57

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  Hypertension overrides the protective effect of female hormones on the development of aortic aneurysm secondary to Alk5 deficiency via ERK activation.

Authors:  Bradley M Schmit; Pu Yang; Chunhua Fu; Kenneth DeSart; Scott A Berceli; Zhihua Jiang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-11-14       Impact factor: 4.733

Review 2.  Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis.

Authors:  Mingyi Wang; Soo Hyuk Kim; Robert E Monticone; Edward G Lakatta
Journal:  Hypertension       Date:  2015-02-09       Impact factor: 10.190

3.  Heat shock protein 90 inhibition by 17-DMAG attenuates abdominal aortic aneurysm formation in mice.

Authors:  Jia Qi; Ping Yang; Bing Yi; Yan Huo; Ming Chen; Jian Zhang; Jianxin Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-01-30       Impact factor: 4.733

4.  Mechanobiological stability: a new paradigm to understand the enlargement of aneurysms?

Authors:  C J Cyron; J S Wilson; J D Humphrey
Journal:  J R Soc Interface       Date:  2014-11-06       Impact factor: 4.118

5.  Binding sites for ETS family of transcription factors dominate the promoter regions of differentially expressed genes in abdominal aortic aneurysms.

Authors:  Jennifer Nischan; Zoran Gatalica; Mindee Curtis; Guy M Lenk; Gerard Tromp; Helena Kuivaniemi
Journal:  Circ Cardiovasc Genet       Date:  2009-10-19

6.  The transcription factor Erg controls endothelial cell quiescence by repressing activity of nuclear factor (NF)-κB p65.

Authors:  Nicola H Dryden; Andrea Sperone; Silvia Martin-Almedina; Rebecca L Hannah; Graeme M Birdsey; Samia Taufiq Khan; Janice A Layhadi; Justin C Mason; Dorian O Haskard; Berthold Göttgens; Anna M Randi
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

7.  Mechanical activation of the angiotensin II type 1 receptor contributes to abdominal aortic aneurysm formation.

Authors:  SarahRose Hall; Nicholas D Ward; Raj Patel; Armaan Amin-Javaheri; Hayes Lanford; R Tyler Grespin; Christine Couch; Ying Xiong; Rupak Mukherjee; Jeffrey A Jones; Jean Marie Ruddy
Journal:  JVS Vasc Sci       Date:  2021-07-24

8.  Diseases of the Aorta and Kidney Disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Pantelis Sarafidis; Sven Martens; Athanasios Saratzis; Daniella Kadian-Dodov; Patrick T Murray; Catherine M Shanahan; Allen D Hamdan; Daniel T Engelman; Ulf Teichgräber; Charles A Herzog; Michael Cheung; Michel Jadoul; Wolfgang C Winkelmayer; Holger Reinecke; Kirsten Johansen
Journal:  Cardiovasc Res       Date:  2022-09-20       Impact factor: 13.081

9.  Plasma cathepsin S and cystatin C levels and risk of abdominal aortic aneurysm: a randomized population-based study.

Authors:  Bing-Jie Lv; Jes S Lindholt; Xiang Cheng; Jing Wang; Guo-Ping Shi
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  The Hsp90 Inhibitor 17-DMAG Attenuates Hyperglycemia-Enhanced Hemorrhagic Transformation in Experimental Stroke.

Authors:  Jiaming Zhang; Kai Wang; Jia Qi; Xiaodong Cao; Feng Wang
Journal:  Biomed Res Int       Date:  2021-02-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.